J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Johnson & Johnson’s plans to spin off its orthopedics business is underway, and the move is expected to, leaders said in its third quarter 2025 earnings call. “We continue to invest at industry ...

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

Staff at the Cork branch of Johnson & Johnson's orthopaedics subsidiary DePuy Synthes have been informed of its parent company's intent to separate it into a standalone business.

The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.

DePuy Synthes has a well established reputation in the inpatient and hospital outpatient department setting. Now, the company is developing a new focus on freestanding ambulatory surgery centers: ...

RAYNHAM, Mass., Aug. 25, 2021 /PRNewswire/ -- The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, will feature new products ...

RAYNHAM, Mass., Aug. 18, 2021 /PRNewswire/ -- Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson,** introduces the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DePuy Synthes received ...

PALM BEACH GARDENS, Fla., Nov. 22, 2021 /PRNewswire/ -- DePuy Synthes, The Orthopaedics Company of Johnson & Johnson*, has launched the UNIUM™ System as the newest addition to its Power Tools ...

The FDA cleared Materialise’s 3D-printed titanium implants for maxillofacial surgery. Johnson & Johnson’s DePuy Synthes unit will distribute the implants in the U.S., starting in mid-September. The ...

Johnson's ($JNJ) DePuy Synthes unit is facing regulators' ire as the FDA slapped the company's recall of its jaw-stabilizing device with a Class I label, its most ...